financetom
Business
financetom
/
Business
/
Market Chatter: State Street Withdraws US Fund Arm From Climate Group
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: State Street Withdraws US Fund Arm From Climate Group
Oct 30, 2025 11:49 AM

02:31 PM EDT, 10/30/2025 (MT Newswires) -- State Street (STT) is withdrawing its US arm from Net Zero Asset Managers, a global coalition of asset managers focused on reducing emissions, Reuters reported Thursday, citing a company spokesperson.

No reason for the move was given, but the spokesperson said the units serving its European clients would remain part of the climate group, according to the report.

The group initially required its members to attain a net-zero portfolio by mid-century but has relaxed its rules as fund firms started pulling out, the report said.

State Street did not immediately reply to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 116.09, Change: -0.66, Percent Change: -0.56

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Marinus Pharmaceuticals Shares Mixed Results From IV Formulated Ganaxolone In Pretreated Seizure Patients
Marinus Pharmaceuticals Shares Mixed Results From IV Formulated Ganaxolone In Pretreated Seizure Patients
Jun 17, 2024
Monday, Marinus Pharmaceuticals Inc ( MRNS ) announced topline results from the Phase 3 RAISE trial evaluating the safety and efficacy of intravenous (IV) ganaxolone for refractory status epilepticus (RSE). In the RAISE trial, patients with RSE who failed at least two antiseizure medications were randomized to IV ganaxolone or placebo in addition to standard-of-care treatment. The intent-to-treat population comprised...
Oil Trading Higher As Expectations Around Increased Demand Offsets Weak China Data
Oil Trading Higher As Expectations Around Increased Demand Offsets Weak China Data
Jun 17, 2024
09:10 AM EDT, 06/17/2024 (MT Newswires) -- Oil traded higher early on Monday on expectations for rising demand during the busy summer season, offsetting weak industrial data from China. West Texas Intermediate crude for July delivery was last seen up US$0.34 to US$78.79 per barrel, while August Brent crude, the global benchmark, was up US$0.36 to US$82.98. The rise comes...
Autodesk Stock Jumps As Activist Investor Pushes For Margin Improvement, Board Changes: The Details
Autodesk Stock Jumps As Activist Investor Pushes For Margin Improvement, Board Changes: The Details
Jun 17, 2024
Autodesk Inc ( ADSK ) shares are trading higher Monday after activist investor Starboard Value purchased a stake of more than $500 million in the company and wrote a letter to shareholders pushing for changes. What Happened: Activist investor Starboard is pushing Autodesk ( ADSK ) to improve margins and make some changes to its board. In a letter released...
Zymeworks Says FDA Clears Investigational New Drug Application for Cancer Therapy
Zymeworks Says FDA Clears Investigational New Drug Application for Cancer Therapy
Jun 17, 2024
09:14 AM EDT, 06/17/2024 (MT Newswires) -- Zymeworks ( ZYME ) said on Monday that the US Food and Drug Administration has cleared the investigational new drug application for its experimental therapy, ZW171, to treat mesothelin-expressing cancers. We look forward to initiating clinical development of ZW171 during 2024 and continuing to advance additional product candidates in our '5 by 5'...
Copyright 2023-2026 - www.financetom.com All Rights Reserved